Mannin Research is a biotechnology company focused on the discovery, development, and commercialization of first-in-class therapeutics for vascular related diseases using the Tie2 mechanism of action. Mannin’s Tie2 platform technology addresses a number of vascular related diseases. Mannin is currently developing host-directed therapeutics to treat Acute Respiratory Distress Syndrome (ARDS) in COVID-19 patients.